Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
V-type proton ATPase subunit e 1 (ATP6V0E1) is a membrane-integral protein that forms part of the V0 sector of the vacuolar ATPase (V-ATPase) complex, a multisubunit enzyme responsible for acidifying intracellular compartments in eukaryotic cells[1][2]. The V-ATPase consists of two sectors: the cytosolic V1 domain, which hydrolyzes ATP, and the membrane-embedded V0 domain, which translocates protons across organelle membranes. ATP6V0E1 is essential for proton transport and the acidification required for protein sorting, zymogen activation, endocytosis, synaptic vesicle loading, and cellular homeostasis[1][2][3]. Mutations in ATP6V0E1 have been linked to diseases affecting bone and the nervous system. While the whole V-ATPase is a validated research target for anticancer and neurodegenerative disease drug discovery, ATP6V0E1-specific targeting in clinical settings remains unexplored due to the complex’s essential physiological roles[2][3].
Inhibitors block proton translocation, leading to impaired organelle acidification, altered vesicular trafficking, and disrupted cellular pH homeostasis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on V-type proton ATPase subunit e 1 (ATP6V0E1).